Galmed Pharmaceuticals Ltd. (GLMD)
4.02
-0.28
(-6.62%)
USD |
NASDAQ |
Aug 24, 16:00
4.02
0.00 (0.00%)
After-Hours: 20:00
Galmed Pharmaceuticals Price to Book Value : 0.2377 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 0.2546 |
| August 20, 2026 | 0.2697 |
| August 19, 2026 | 0.2821 |
| August 18, 2026 | 0.2651 |
| August 17, 2026 | 0.2429 |
| August 14, 2026 | 0.2475 |
| August 13, 2026 | 0.2513 |
| August 12, 2026 | 0.265 |
| August 11, 2026 | 0.2635 |
| August 10, 2026 | 0.2806 |
| August 07, 2026 | 0.2848 |
| August 06, 2026 | 0.2834 |
| August 05, 2026 | 0.2744 |
| August 04, 2026 | 0.2723 |
| August 03, 2026 | 0.2768 |
| July 31, 2026 | 0.2938 |
| July 30, 2026 | 0.2834 |
| July 29, 2026 | 0.2648 |
| July 28, 2026 | 0.2527 |
| July 27, 2026 | 0.2494 |
| July 24, 2026 | 0.2427 |
| July 23, 2026 | 0.2617 |
| July 22, 2026 | 0.2389 |
| July 21, 2026 | 0.2456 |
| July 20, 2026 | 0.2435 |
| Date | Value |
|---|---|
| July 17, 2026 | 0.2583 |
| July 16, 2026 | 0.2603 |
| July 15, 2026 | 0.243 |
| July 14, 2026 | 0.2419 |
| July 13, 2026 | 0.254 |
| July 10, 2026 | 0.265 |
| July 09, 2026 | 0.2697 |
| July 08, 2026 | 0.2697 |
| July 07, 2026 | 0.2692 |
| July 06, 2026 | 0.2636 |
| July 02, 2026 | 0.2699 |
| July 01, 2026 | 0.3065 |
| June 30, 2026 | 0.2632 |
| June 29, 2026 | 0.2701 |
| June 26, 2026 | 0.2714 |
| June 25, 2026 | 0.2714 |
| June 24, 2026 | 0.278 |
| June 23, 2026 | 0.2707 |
| June 22, 2026 | 0.2669 |
| June 18, 2026 | 0.2744 |
| June 17, 2026 | 0.284 |
| June 16, 2026 | 0.2859 |
| June 15, 2026 | 0.2915 |
| June 12, 2026 | 0.2896 |
| June 11, 2026 | 0.2914 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioLineRx Ltd. | 0.7308 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 1.802 |
| Can-Fite BioPharma Ltd. | 2.381 |
| Revium Recovery, Inc. | -- |
Price to Book Value Related Metrics
| Price | 4.02 |
| Earnings Yield | -398.1% |
| Market Cap | 3.316M |